ArticleStem cell research & therapy2025
Harnessing TGF-β signaling to improve testicular organoid development from dissociated testicular cells.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Post-translational modification of proteins in the human testis development pathway.Human reproduction update · 2026Review
- From Cells to Organoids: Approaches, Regulatory Mechanisms, Applications, and Challenges of Organoids.Cells · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTesticular organoids (TOs) have generated great interest in reproductive biology as a reliable experimental tissue model for pharmaco-toxicology studies and therapeutic applications. However, current TOs mostly fail to recapitulate the native testicular architecture and function, likely due to an imbalance between the spermatogonia and functional niche cells. TGF-β signaling pathway is a critical regulator of testis development that can be harnessed to regulate the testicular cells' behavior. Based on our previous finding on the crucial role of TGF-β inhibition in promoting spermatogonia proliferation and differentiation, we have developed a novel approach to improve TO development from dissociated testicular cells.
methodsThe testicular cells were isolated from prepubertal mice, encapsulated within inner core of Matrigel-based core-shell hydrogel droplets hanging from filter inserts, and exposed to the small molecule TGF-β inhibitors, SB431542 (SB) or LY2157299 (LY).
resultsAccording to our results, TGF-β inhibition considerably improved formation of spherical-tubular structures (STSs), resembling the compartmentalized architecture of native testicular tissue, as indicated by increased number, size and average area of the STSs. The TGF-β inhibitor-derived TOs (TiTOs) revealed more profoundly a tissue-specific spatial expression pattern of testicular markers and superior steroidogenic activity in response to gonadotropin stimulation (3.69-fold and 3.00-fold vs. the untreated control in the SB and LY-treated groups, respectively). The stimulatory effects of the TGF-β inhibition were attributed to the promoted proliferation of cells, as demonstrated by up-regulation of cell cycle promoting genes, down-regulation of proliferation inhibitor genes, and up-regulation of proliferation genes, as well as increased number of proliferative germ cells in the treated TOs.
conclusionThis work presents a simple and efficient method for development of well-organized and functional TOs which can be investigated as a complementary treatment with any other TO culture systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.